Kang, Dongwoo http://orcid.org/0000-0001-9057-6748
Ludwig, Elizabeth
Jaworowicz, David
Huang, Hannah
Fiedler-Kelly, Jill
Cortes, Jorge
Ganguly, Siddhartha
Khaled, Samer
Krämer, Alwin
Levis, Mark
Martinelli, Giovanni
Perl, Alexander
Russell, Nigel
Abutarif, Malaz
Choi, Youngsook
Yin, Ophelia
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 14 August 2020
Accepted: 16 November 2020
First Online: 8 January 2021
Compliance with ethical standards
:
: D. Kang and M. Abutarif are employees and shareholders of Daiichi Sankyo, Inc. E. Ludwig, D. Jaworowicz, H. Huang, and J. Fiedler-Kelly are employees of Cognigen Corporation, which provided consulting services and received financial support from Daiichi Sankyo, Inc, to perform the analyses described. J. Cortes received grants and personal fees from Daiichi Sankyo, Inc, Astellas, Novartis, Pfizer, Jazz Pharmaceuticals, and Bio-Path Holdings and grants from Amphivena and Merus. S. Ganguly received research support from Daiichi Sankyo, Inc, and personal fees from Seattle Genetics. S. Khaled received travel support from Daiichi Sankyo, Inc. A. Krämer received travel support from the University of Heidelberg. M. Levis received grants and personal fees from Astellas and FujiFilm and grants from Agios and Amgen. G. Martinelli received personal fees from Amgen, Daiichi Sankyo, Inc, Celgene, AbbVie, Novartis, and Jazz Pharmaceuticals. A. Perl received grants, personal fees, and travel support from Daiichi Sankyo, Inc, and Astellas, grants and personal fees from Novartis, grants from FujiFilm, and nonfinancial support from Arog. N. Russell has nothing to disclose. Y. Choi and O. Yin are employees of Daiichi Sankyo, Inc.
: The institutional review board or ethics committee at each site approved the study protocol, and all patients provided written informed consent per the Declaration of Helsinki and Good Clinical Practice.
: De-identified individual participant data (IPD) and applicable supporting clinical trial documents may be available upon request at ExternalRef removed. In cases where clinical trial data and supporting documents are provided pursuant to our company policies and procedures, Daiichi Sankyo, Inc, will continue to protect the privacy of our clinical trial participants. Details on the data sharing criteria and the procedure for requesting access can be found at this web address: ExternalRef removed